REFERENCES
- West R. Theories of addiction. Addiction 2001; 96: 3–13
- Blum K, Braverman E R, Holder J M, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 2000; 32(Suppl:i–iv)1–112, Suppl:i–iv
- Wikler A. Recent progress in research on the neurophysiological basis of morphine addiction. Am J Psychiatry 1948; 105: 329–338
- Koob G F, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97–129
- Koob G F, Caine S B, Parsons L, Markou A, Weiss F. Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav 1997; 57: 513–521
- Paterson N E, Myers C, Markou A. Effects of repeated withdrawal from continuous amphetamine adminstration on brain reward function in rats. Psychopharmacology. (Berl) 2000; 152: 440–446
- Solomon R L, Corbit J D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev 1974; 81: 119–145
- Spence K W. Behavior theory and conditioning. Yale University Press, New Haven 1956
- Stewart J, de Wit H, Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 1984; 91: 251–268
- Wise R A, Bozarth M A. Brain mechanisms of drug reward and euphoria. Psychiatr Med 1985; 3: 445–460
- Robinson T E, Berridge K C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993; 18: 247–291
- Berridge K C, Robinson T E. The mind of an addicted brain: Neural sensitization of wanting versus liking. Current Directions in Psychological Science 1995; 4: 71–76
- Robinson T E, Berridge K C. Addiction. Annu Rev Psychol 2003; 54: 25–53
- Everitt B J, Dickinson A, Robbins T W. The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev 2001; 36: 129–138
- Everitt B J, Belin D, Economidou D, Pelloux Y, Dalley J W, Robbins T W. Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3125–3135
- de Wit H, Richards J B. Dual determinants of drug use in humans: reward and impulsivity. Nebr Symp Motiv 2004; 50: 19–55
- de Wit H, Enggasser J L, Richards J B. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002; 27: 813–825
- Miller L. Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style. J Subst Abuse Treat 1991; 8: 277–291
- Poulos C X, Le A D, Parker J L. Impulsivity predicts individual susceptibility to high levels of alcohol self-administration. Behav Pharmacol 1995; 6: 810–814
- Jentsch J D, Taylor J R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999; 146: 373–390
- Gray J A. Perspectives on anxiety and impulsivity: A commentary. Journal of Research in Personality 1987; 21: 493–509
- Jentsch J D, Olausson P, De La Garza R, 2nd, Taylor J R. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 2002; 26: 183–190
- Newton T F, Roache J D, De La Garza R, 2nd, et al. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 2006; 31: 1537–1544
- McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White J M. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100: 1320–1329
- Newton T F, Kalechstein A D, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict 2004; 13: 248–255
- De L a, Garza R, Shoptaw S, Newton T FD. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol 2008; 11: 729–741
- Hartz D T, Frederick-Osborne S L, Galloway G P. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend 2001; 63: 269–276
- Monterosso J R, Aron A R, Cordova X, Xu J, London E D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005; 79: 273–277
- Vanderschuren L JMJ, Everitt B J. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 2004; 305: 1017–1019
- Deroche-Gamonet V, Belin D, Piazza P V. Evidence for addiction-like behavior in the rat. Science 2004; 305: 1014–1017
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington, DC 1994
- Sheehan D V, Lecrubier Y, Sheehan K H, et al. The Mini-International Neuropsychiatric Interview (M. I. N. I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(Suppl 20)22–33, quiz 34–57
- McLellan A T, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199–213
- Beck A T, Steer R A, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588–597
- Robinson T E, Berridge K C. Addiction. Annu Rev Psychol 2003; 54: 25–53
- Koob G F, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52–58
- Newton T F, De La Garza R, 2nd, Fong T, et al. A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacol Biochem Behav 2005; 82: 704–711
- Wilson J M, Kalasinsky K S, Levey A I, et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996; 2: 699–703
- Everitt B J, Robbins T W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005; 8: 1481–1489
- Evenden J L. Varieties of impulsivity. Psychopharmacology (Berl) 1999; 146: 348–361
- Addolorato G, Leggio L, Abenaveli L, Gasbarrini G. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 2005; 30: 1209–1224
- O'Brien C P. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 2005; 162: 1423–1431
- Shiffman S, West R, Gilbert D. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res 2004; 6: 599–614
- Robbins S J, Ehrman R N, Childress A R, O'Brien C P. Relationships among physiological and self-report responses produced by cocaine-related cues. Addict Behav 1997; 22: 157–167
- Ehrman R N, Robbins S J, Childress A R, O'Brien C P. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 1992; 107: 523–529
- Bruehl A M, Lende D H, Schwartz M, Sterk C E, Elifson K. Craving and control: methamphetamine users' narratives. J Psychoactive Drugs 2006; 385–392, Suppl 3
- Weiss R D, Griffin M L, Mazurick C, et al. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry 2003; 160: 1320–1325
- Kosten T R, Scanley B E, Tucker K A, et al. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 2006; 31: 644–650
- De L a, Garza I R, Newton T F. Individual variability in addiction profiles: Importance for medications development. Annual Meeting of The College on the Problems of Drug Dependence. Scottsdale, AZ 2006
- Williamson A. Using self-report measures in neurobehavioural toxicology: can they be trusted?. Neurotoxicology 2007; 28: 227–234
- Monterosso J, Ehrman R, Napier K L, O'Brien C P, Childress A R. Three decision-making tasks in cocaine-dependent patients: do they measure the same construct?. Addiction 2001; 96: 1825–1837